Kim R. Tsuchimoto, Director at Monopar Therapeutics (MNPR), sold 4,090 shares at $108.83 ($456K) on 2026-08-26, disclosed to the SEC on 2026-08-27.
Scheduled sale ($456k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.83 | 485 | $53K | 11.6% |
| 2 | $109.56 | 615 | $67K | 14.8% |
| 3 | $110.65 | 700 | $77K | 17.0% |
| 4 | $111.84 | 1,098 | $123K | 27.0% |
| 5 | $112.93 | 602 | $68K | 14.9% |
| 6 | $113.84 | 590 |
| $67K |
| 14.7% |
| Total | $111.39 avg | 4,090 | $456K | 100% |
| Filing → |
| RPTP | SELL | 2012-08-31 | $18K | — | Filing → |
| RPTP | SELL | 2012-08-29 | $245 | — | Filing → |
| RPTP | SELL | 2012-06-18 | $21K | — | Filing → |